Ebola virus disease and the eye

Current Opinion in Ophthalmology

Volumn 27, Issue 6, 2016, Pages 538-544

  Shantha, Jessica G ^a   Yeh, Steven ^b   Nguyen, Quan Dong ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY EYE CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Ebola Virus Disease; Filovirus; Post Ebola Syndrome; Uveitis; West Africa

Indexed keywords

ANTIVIRUS AGENT; VIRUS RNA;

CATARACT; CLINICAL FEATURE; CONJUNCTIVAL HEMORRHAGE; CONJUNCTIVITIS; CONVALESCENCE; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EYE DISEASE; HUMAN; INFECTION COMPLICATION; INFECTION CONTROL; INTERMEDIATE UVEITIS; IRIDOCYCLITIS; NONHUMAN; PAPILLEDEMA; PRIORITY JOURNAL; RETINA EDEMA; REVIEW; SCLERITIS; UVEITIS; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; VISUAL IMPAIRMENT; BLEEDING; COMPLICATION; VIRAL EYE INFECTION; VIROLOGY; VISUAL DISORDER;

CONJUNCTIVITIS; EYE INFECTIONS, VIRAL; HEMORRHAGE; HEMORRHAGIC FEVER, EBOLA; HUMANS; UVEITIS; VISION DISORDERS;

EID: 84984704771     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0000000000000313     Document Type: Review

References (34)

1. Weyer J, Grobbelaar A, Blumberg L. Ebola virus disease: history, epidemiology and outbreaks. Curr Infect Dis Rep 2015; 17:480.
2. World Health Organization: Ebola Situation Report 10 June 2015
3. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371:1418-1425.
4. World Health Organization: Statement on the 9th meeting of the IHR Emergency Committee regarding the Ebola outbreak in West Africa 29 March 2016
5. Goeijenbier M, van Kampen JJ, Reusken CB, et al. Ebola virus disease: A review on epidemiology, symptoms, treatment and pathogenesis. Neth J Med 2014; 72:442-448.
6. World Health Organization: Ebolavirus Disease Fact Sheet. January 2016
7. Falasca L, Agrati C, Petrosillo N. Molecular mechanisms of Ebola virus pathogenesis: focus on cell death. Cell Death Differ 2015; 22:1250-1259.
8. World Health Organization: Laboratory diagnosis of Ebolavirus disease. September 2014 9.
9. Uyeki TM, Mehta AK, Davey RT Jr, et al. Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med 2016; 374:636-646.
10. Warren TK, Jordan R, Lo MK, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 2016; 531:381-385.
11. Qureshi AI, Chughtai M, Loua TO, et al. Study of Ebola virus disease survivors in Guinea. Clin Infect Dis 2015; 61:1035-1042.
12. Nanyonga M, Saidu J, Ramsay A, Shindo N. Sequelae of Ebola virus disease, Kenema district, Sierra Leone. Clin Infect Dis 2016; 62:125-126.
13. Clark DV, Kibuuka H, Millard M, et al. Long-Term sequelae after Ebola virus disease in Bundibugyo, Uganda: A retrospective cohort study. Lancet Infect Dis 2015; 15:905-912.
14. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999; 179 (suppl 1):S1-S7.
15. Wendo C. Caring for the survivors of Ugandas Ebola epidemic one year on. Lancet 2001; 358:1350.
16. Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic followup of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies a Kikwit. J Infect Dis 1999; 179 (suppl 1):S28-S35.
17. Kibadi K, Mupapa K, Kuvula K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis 1999; 179 (Suppl 1):S13-S14.
18. Piot P, Sureau P, Breman G, et al. Clinical aspects of Ebola virus infection in Yambuku area, Zaire, 1976. In: Pattyn SR, editor. Ebola virus haemorrhagic fever. Amsterdam, the Netherlands: Elsevier/North-Holland Biomedical Press; 1978. pp. 7-14.
19. Chertow DS, Nath A, Suffredini AF, et al. Severe meningoencephalitis in a case of Ebola virus disease: A case report. Ann Intern Med 2016; doi: 10.7326/M15-3066. [Epub ahead of print]
20. Chancellor JR, Padmanabhan SP, Greenough TC, et al. Uveitis and systemic inflammatory markers in convalescent phase of Ebola virus disease. Emerg Infect Dis 2016; 22:295-297.
21. Varkey JB, Shantha JG, Crozier I, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 2015; 372:2423-2427.
22. Vetter P, Kaiser L, Schibler M, et al. Sequelae of Ebola virus disease: The emergency within the emergency. Lancet Infect Dis 2016; 16:e82-e91.
23. Mattia JG, Vandy MJ, Chang JC, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: A cross-sectional study. Lancet Infect Dis 2015; 16:331-338.
24. Tiffany A, Vetter P, Mattia J. Ebola virus disease complications as experienced by survivors in Sierra Leone. Clin Infect Dis 2016; 62:1360-1366.
25. Shantha JG, Crozier I, Hayek B, et al. Ophthalmic manifestations of Ebola virus disease survivors in Monrovia, Liberia. ARVO Abstracts 2016; 4762.
26. Uyeki TM, Erickson BR, Brown S, et al. Ebola virus persistence in semen of male survivors. Clin Infect Dis 2016; 62:1552-1555.
27. Muehlenbachs A, de la Rosa Vázquez O, Bausch DG, et al. Ebola virus disease in pregnancy: clinical, histopathologic, and immunohistochemical findings. J Infect Dis 2016. [Epub ahead of print]
28. Howlett P, Brown C, Helderman T, et al. Ebola virus disease complicated by late-onset encephalitis and polyarthritis, Sierra Leone. Emerg Infect Dis 2016; 22:150-152.
29. Rodriguez LL, De Roo A, Guimard Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1995; 179:S170-S176.
30. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011; 377:849-862.
31. Kondratowicz AS, Lennemann NJ, Sinn PL, et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci U S A 2011; 108:8426-8431.
32. Larsen T, Stevens EL, Davis KJ, et al. Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. J Infect Dis 2007; 196 (Suppl 2):S323-S328.
33. Kuming BS, Kokoris N. Uveal involvement in Marburg virus disease. Br J Ophthalmol 1977; 61:265-266.
34. Henao-Restrepo AM, Longini IM, Egger M, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015; 386:857-866.